Watch Now

November 11, 2024 | Comparative Oncology of Leukemias and Myeloproliferative Disorders in Veterinary and Human Patients

Presented by:
Ellin Berman, MD & Brooke Britton, DVM, DACVIM (Oncology)

November 12, 2024 | Comparative Oncology and Translational Aspects of Oral Tumors in Human and Veterinary Patients

Presented by:
Jay Neugarten, DDS, MD, FACS & Jonathan Ferrari, VMD, DACVS (SA), ACVS Fellow, Surgical Oncology

November 13, 2024 | Comparative Oncology and Translational Aspects of Meningiomas in Human and Veterinary Patients

Presented by:
Kathryn Beal, MD & Rachel St-Vincent, DVM, MVSc, DACVR (RO)

November 14, 2024 | Comparative Oncology and Translational Aspects of Breast Cancer in Human and Veterinary Patients

Presented by:
Larry Norton, MD, FASCO, FAACR & Nicole Leibman, DVM, MS, DACVIM (Oncology)

November 18, 2024 | Comparative Oncology and Translational Aspects of Common Cutaneous Tumors in Human and Veterinary Patients 

Presented by:
Anna C. Pavlick, BSN, MSc, DO, MBA & Margaret Wong, DVM

November 19, 2024 | Comparative Oncology of Melanocytic Neoplasms in Veterinary and Human Patients

Presented by:
Jedd Wolchok, MD, PhD, FASCO, FAACR & Rachel Lordahl, DVM

Our Speakers

Comparative Oncology of Leukemias and Myeloproliferative Disorders in Veterinary and Human Patients

Ellin Berman, MD
Attending Physician and Leukemia Specialist at Memorial Sloan Kettering Cancer Center

Dr. Ellin Berman is a board-certified medical oncologist and hematologist with a clinical and research focus on new drug development in acute and chronic leukemias, including acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML). She received her medical degree from Harvard Medical School and has been in practice for more than 20 years. As a member of the multidisciplinary Leukemia Disease Management Team, she works closely with the many individuals who make up the clinical and research programs at Memorial Sloan Kettering.

Brooke Britton, DVM, DACVIM (Oncology)
Senior Veterinarian in Oncology at the Schwarzman Animal Medical Center

Dr. Brooke Britton is a native New Yorker, growing up on Long Island and returning to New York City to reside after completion of her veterinary training. She obtained her veterinary degree at Cornell, and completed her residency in Medical Oncology at the University of Pennsylvania. Dr. Britton has been in clinical practice as a board-certified Diplomate of the American College of Veterinary Internal Medicine in Oncology since 2012 in New York, New Jersey, and California, the majority of those years as Head of Service for the Brooklyn and Downtown Manhattan Oncology departments of a large multi-specialty hospital network, where she was active in-house officer training and clinical trials development. Dr. Britton was subsequently appointed the Director of Clinical Development for Veritas Veterinary Partners, a nationwide network of veterinary ER and specialty hospitals, where she architected and implemented clinical training and wellness initiatives within partner practices to strategically drive medical excellence and practice growth. She has lectured nationally, and is a peer-reviewed author, medical editor, and medical podcaster.

Dr. Britton joined the AMC as a Senior Veterinarian in the Cancer institute in 2023 to return to her passion for clinical practice, house officer training, and clinical research. While she provides comprehensive care for all cancer types, her particular interests lie in the treatment of hematologic malignancies, the use of small molecular inhibitor therapy and immunotherapy in veterinary cancer patients, and the multimodal treatment of metastatic cancers. Her practice philosophy is heavily quality-of-life-centered, while delivering the highest standard of oncologic care. Outside of clinical practice, Dr. Britton enjoys aerial fitness, forest bathing, travel, photography, and long strolls in NYC with her French Bulldog.

Comparative Oncology and Translational Aspects of Oral Tumors in Human and Veterinary Patients

Jay Neugarten, DDS, MD, FACS
Oral and Maxillofacial Surgeon at the New York Center for Orthognathic and Maxillofacial Surgery and NewYork-Presbyterian Hospital/Weill Medical Center

Dr. Neugarten is a graduate of the Columbia University School of Dental and Oral Surgery, where he was named class valedictorian and earned membership in the national dental honor society, Omicron Kappa Upsilon. He completed his residency at North Shore University-Long Island Jewish Medical Center, and earned a medical degree from the Stony Brook School of Medicine.

Dr. Neugarten is the oral and maxillofacial surgical member for the craniofacial team at New York Hospital Cornell-Weill Medical Center. He is a nationally known specialist in oral and maxillofacial surgery, whose areas of expertise include working with patients requiring both complex implant and bone-grafting construction, as well as with those whose skeletal facial and craniofacial deformities require corrective jaw surgery and distraction osteogenesis, from neonate to adult. His other areas of specialization include Temporomandibular Joint (TMJ) Reconstructive Surgery, Dentoalveolar and complex Reconstruction Surgery using the most advanced surgical technology.

Dr. Neugarten is a fellow of the American College of Surgeons, an educational association whose physicians must pass a set of rigorous qualifications for membership. He is an associate clinical professor at both New York Hospital Cornell-Weill Medical Center and North Shore University-Long Island Jewish Medical Center, where he is an active educator of oral and maxillofacial residents.

Dr. Neugarten lectures both nationally and internationally on a variety of topics of oral and maxillofacial surgery. These topics include Distraction Osteogenesis from the neonate to the adult patient, Implant Reconstruction, Orthognathic and Craniofacial Surgery.

Dr. Neugarten’s attention to detail and philosophy of providing quality care to his patients with the least amount of surgery has earned him trust from patients and confidence from referring doctors.

Jonathan Ferrari, VMD, DACVS (SA), ACVS Fellow, Surgical Oncology
Service Head of Surgical Oncology at the Schwarzman Animal Medical Center

Dr. Jonathan Ferrari came to the Schwarzman Animal Medical Center by way of Philadelphia, having graduated from the University of Pennsylvania School of Veterinary Medicine in 2017. He completed a one-year rotating internship in small animal medicine and surgery here at the Animal Medical Center and continued on as a resident in surgery, where he was the Kovner Surgery Resident. Following residency, he completed a fellowship in surgical oncology at the Colorado State University Veterinary Teaching Hospital. He is certified as a Diplomate of the American College of Veterinary Surgeons in Small Animal Surgery and a Fellow in Surgical Oncology. He is committed now to providing comprehensive care for dogs and cats with cancer, and pursues clinical research to better treat patients fighting cancer. Beyond veterinary medicine, he enjoys cooking, running, and attending theatre and music events in the city.

Comparative Oncology and Translational Aspects of Meningiomas in Human and Veterinary Patients

Kathryn Beal, MD
Associate Attending Radiation Oncologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center

Dr. Kathryn Beal is a board-certified radiation oncologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Beal received her BA from Harvard College, then received her medical degree from the College of Physicians and Surgeons at Columbia University, and completed her residency in Radiation Oncology at Memorial Sloan Kettering Cancer Center where she was also elected Chief Resident.

Following residency, Dr. Beal was the Director of the Brain Tumor Program in the Department of Radiation Oncology at MSKCC. She was involved with a number of treatment protocols of radiation therapy for brain tumors as well as imaging of brain tumors as related to radiation therapy planning and treatment response. She was awarded an R21 grant to investigate the use of “18F-Fluorocholine to distinguish necrosis from recurrence in brain metastases.” She personally treated 200 brain metastases patients per year with stereotactic radiosurgery and managed these patients long-term.

Dr. Beal has published and presented several original studies that demonstrate a change in response and improved outcome in patients treated with the combination of SRS and immunotherapy and has become a leader in this emerging field.

Rachel St-Vincent, DVM, MVSc, DACVR (RO)
Service Head of Radiation Oncology at the Schwarzman Animal Medical Center

Dr. Rachel St-Vincent received her Doctorate in Veterinary Medicine from the University of Montreal and completed a one-year internship program in small animal medicine and surgery at Washington State University. She completed a residency program in veterinary radiology and earned a Master of Science Degree at Western College of Veterinary Medicine at the University of Saskatchewan in Saskatoon, Canada. She did her clinical training in radiation oncology at the Animal Cancer Treatment Center and William Beaumont Teaching Hospital in Michigan.

Comparative Oncology and Translational Aspects of Breast Cancer in Human and Veterinary Patients

Larry Norton, MD, FASCO, FAACR
Norna S. Sarofim Chair of Clinical Oncology at Memorial Sloan Kettering Cancer Center and Senior Vice President in the Office of the President and Medical Director of the Evelyn H. Lauder Breast Center

Larry Norton, MD, Memorial Sloan Kettering’s Norna S. Sarofim Chair of Clinical Oncology, is the Senior Vice President in the Office of the President and Medical Director of the Evelyn H. Lauder Breast Center. In 1993 he co-founded, with Evelyn H. Lauder, the Breast Cancer Research Foundation. He is a Past-President of the American Society of Clinical Oncology and is a Fellow of ASCO, the American Association for Cancer Research Academy, and the American Academy of Arts and Sciences. His research is broad with more than 400 published articles, but he is best known for mathematical insights in cancer therapy and biology. Major honors include ASCO’s Karnofsky and Bonadonna Awards, Columbia University’s Gold Medal, and Cold Spring Harbor Laboratory’s Double Helix Award.

Nicole Leibman, DVM, MS, DACVIM (Oncology)
Director of the Cancer Institute, Service Head of Oncology, and Oncology Program Residency Director at the Schwarzman Animal Medical Center

Dr. Nicole Leibman received her DVM from the University of Minnesota, did her internship at the Animal Medical Center, and completed her medical oncology residency at Colorado State University. She has been practicing clinical oncology for over 20 years in the New York metropolitan area. She joined AMC as a Senior Veterinarian in 2001 and has since conducted clinical trials and published results on the canine melanoma vaccine for both oral and digit tumors, feline oral squamous cell carcinoma, and feline breast cancer. Dr. Leibman has also studied the treatment of mast cell tumors in dogs and published several studies on the staging and treatment of this disease.

Dr. Leibman collaborates with Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center, and NYU Langone for teaching and research purposes.

Comparative Oncology and Translational Aspects of Common Cutaneous Tumors in Human and Veterinary Patients 

Anna C. Pavlick, BSN, MSc, DO, MBA
Attending Physician at NewYork-Presbyterian Hospital and Professor of Medicine at Weill Cornell Medical College, Cornell University

Anna Pavlick, BSN, MSc, DO, MBA is a medical oncologist with over 20 years of experience treating patients with skin cancer, including melanoma, basal cell cancer, squamous cell cancer and Merkel cell carcinoma. She is also an expert in treating ocular melanoma, eyelid tumors and other rare solid tumor malignancies, including a research interest in neurofibromatosis-1 (NF1) malignancies. Dr. Pavlick was recruited to Weill Cornell Medicine as Professor of Medicine in the Division of Hematology & Medical Oncology. She is the founding Director of the Cutaneous Oncology Program at Weill Cornell Medicine and NewYork-Presbyterian. Dr. Pavlick’s major research interests include investigating targeted therapies, combination therapies and immunotherapies. She also conducts outcomes research evaluating quality of life. Dr. Pavlick earned her medical degree from the University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School; her Master of Science in Human Anatomy from Fairleigh Dickinson University; and her Bachelor of Science in Biology and Nursing degree from Fairfield University. She completed an internal medicine residency at UMDNJ and hematology and oncology fellowship training at Memorial Sloan Kettering Cancer Center. In addition to her undergraduate and medical training, Dr. Pavlick graduated from the Drexel School of Medicine Executive Leadership in Academic Medicine in 2012 and earned her Master of Business Administration (MBA) degree from Columbia University Business School in 2017. Dr. Pavlick has authored and co-authored over 100 publications and presented her research at international meetings. She serves on the several editorial boards, including The Journal of Drugs in Dermatology and The Journal of ImmunoTherapeutics of Cancer (Associate Editor). She is a member of leading oncology societies including American Society of Clinical Oncology (ASCO), American Academy of Clinical Research (AACR), the Society for Melanoma Research, Society for Immunotherapy and Translational Research in Cancer, and the European Society of Medical Oncology (ESMO).

Margaret Wong, DVM
Resident Veterinarian in Oncology at the Schwarzman Animal Medical Center

Dr. Margaret Wong received her Doctorate in Veterinary Medicine from Washington State University College of Veterinary Medicine in 2021. This was followed by an internship in Medicine and Surgery in 2022, as well as a specialty internship in Oncology in 2023, both at the Schwarzman Animal Medical Center. Dr. Wong is currently a Resident in Medical Oncology at AMC.

Comparative Oncology of Melanocytic Neoplasms in Veterinary and Human Patients

Jedd Wolchok, MD, PhD, FASCO, FAACR
Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and Professor of Medicine at Weill Cornell College

Jedd Wolchok, MD, PhD, FASCO, FAACR, is the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and Professor of Medicine at Weill Cornell College. Dr. Wolchok is a clinician-scientist exploring innovative immunotherapeutic strategies in laboratory models, and a principal investigator in numerous pivotal clinical trials. Dr. Wolchok helped establish immunotherapy as a standard approach to cancer treatment and was instrumental in the clinical development leading to the approval of ipilimumab and the combination of nivolumab and ipilimumab for advanced melanoma. He supervises an NIH R01-funded basic science laboratory which is focused on investigating novel immunotherapeutic agents in pre-clinical laboratory models. The focus of his translational research laboratory is to investigate innovative means to modulate the immune response to cancer as well as to better understand the mechanistic basis for sensitivity and resistance to currently available immunotherapies. Dr. Wolchok received his BA degree from Princeton University, and his MS, PhD and MD degrees from New York University. Dr. Wolchok has received numerous honors for his work including: American Association for Cancer Research (AACR) Richard and Hinda Rosenthal Memorial Award, the Giants of Cancer Care in Melanoma Award, the Berson Alumni Achievement Award in Clinical and Translational Science and the Zelmanovich Young Alumni Achievement Award from NYU Grossman School of Medicine, the Alfred Taubman Prize for Excellence in Translational Medical Research (Univ of Michigan) and has been designated a Fellow of the American Society of Clinical Oncology (FASCO), as well as board of directors. He has been awarded the Distinguished Alumni Award at MSK, the AACR-Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research, the ESMO Award for Immuno-Oncology and the David Karnofsky Award from ASCO. Dr. Wolchok has served on the Board of Directors of ASCO and the Society for Immunotherapy of Cancer (SITC) and currently is the Treasurer of SITC. He is an elected member of American Association for Cancer Research (AACR) board of directors, elected to the AACR academy of fellows (FAACR), the American Society for Clinical Investigation (ASCI), Association of American Physicians (AAP) and is Chair of the Melanoma Committee for the ECOG-ACRIN NCI cooperative group. Most recently he has been elected to the National Academy of Medicine (NAM). He is a full member of the Ludwig Institute for Cancer Research and center director for the Parker Institute of Cancer Immunotherapy.

Rachel Lordahl, DVM
Resident Veterinarian in Oncology at the Schwarzman Animal Medical Center

Dr. Rachel Lordahl received her Doctorate in Veterinary Medicine from Atlantic Veterinary College in 2019. This was followed by an internship in Medicine and Surgery as well as a specialty internship in Medical and Radiation Oncology at the Veterinary Medical Center of Long Island. In 2021, Dr. Lordahl joined the Schwarzman Animal Medical Center where she completed a specialty internship in Oncology and is now currently a Resident in Medical Oncology.